Commentary · 21 Feb 2026
Conference abstractPublished 26 Sep 2016
Salivary biomarkers in the diagnosis of oral potentially malignant disorders: A systematic review and meta-analysis
University of BrasÃ?lia, Brazil
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The aim of this systematic review was to evaluate the accuracy of salivary biological markers in the diagnostic of oral potentially malignant disorders (OPMD). This study followed the preferred reporting items for systematic reviews and meta-analyses checklist. Studies were gathered by searching EMBASE, LILACS, PubMed, Science Direct, Scopus and Web of Science. A grey literature search was undertaken using Google Scholar, ProQuest and Open Grey. The search was performed on January 13, 2016, with no time and language restrictions. Selected studies were evaluated according the quality assessment tool for diagnostic accuracy studies. 6 studies were identified and subjected to qualitative and quantitative analyses. The studies were homogeneous and all had high methodological quality, so it was possible to make the meta-analysis of data. Additional analysis was performed using, diagnostic odds ratio (DOR) and Youden index (YI). 8-hydroxydeoxyguanosine, an oxidative stress marker when combined with malondialdehyde and vitamin C or E demonstrated better accuracy (YI=0.64, DOR=20.75 and 20.81, respectively) with higher sensitivity and specificity, in oral leukoplakia, oral lichen planus and oral submucous fibrosis. A single biomarker CD4+CD25+Regulatory T cells had a better accuracy diagnostic (YI=0.73, DOR=43.94), in oral lichen planus. There is currently limited evidence to confirm the putative implementation of salivary biomarkers as diagnostic tools for OPMD. Although, there are few studies on this topic, current systematic review provides new research directions.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Cancer Science & Therapy.
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Daniela Fortunato Rego”
